Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Songguoju Yanhoshuang lozenges is a Traditional Chinese Medicine (TCM) formulation developed by the Beijing Beiyi Modern Traditional Chinese Medicine Technology Development Center for the treatment of acute and chronic pharyngitis. The product contains extracts of *Echinacea* (Songguoju), which is traditionally utilized for its anti-inflammatory and immunomodulatory properties. It has been evaluated in Phase 2 clinical trials in China (e.g., CTR20140600) to assess its efficacy and safety in adults, comparing it against established TCM treatments such as Fufang Caoshanhu lozenges.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Songguoju Yanhoshuang lozenges.